Tags : Investment

CEPI Expands its Investment in the Development of Vaccine Against

Shots: CEPI to provide $4.4M to Novavax & the University of Oxford for accelerating the development of vaccines against COVID-19. CEPI has invested up to $23.7M in R&D of COVID-19 vaccines Novavax is assessing multiple nanoparticle vaccine candidates to identify the best candidates for clinical studies. CEPI will provide the initial funding to Novavax for […]Read More

Boehringer Ingelheim and Lilly Restructure their Alliance to Emphasis Full

Shots: The global companies modernize their alliance as of Jan 01, 2020 to completely focus their expertise and investment on the development and commercialization of Jardiance (empagliflozin) for T2D, HF and CKD   As per the amended agreement, the companies will revise the margin sharing structure for ongoing payments from Jan 01, 2020. Trajenta (linagliptin) […]Read More